Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada.
Department of Occupational Science and Occupational Therapy, University of Toronto, Toronto, Ontario, Canada
BMJ Open. 2022 May 16;12(5):e058783. doi: 10.1136/bmjopen-2021-058783.
Bipolar disorder (BD) is a severe mental health disorder that affects 2% of the adult population. Individuals with this disorder are at a higher risk for morbidity and functional difficulties. They may also experience significant challenges in their activities of daily living (ADLs). This systematic review will identify all available studies that examine subsets of ADLs that impact individuals with BD.
MEDLINE, Embase, CINAHL and APA PsycINFO will be searched to identify observational studies that examined functioning, independence or performance across a variety of ADLs. Title and abstract, full-text screening and a risk of bias assessment will be conducted in duplicate. An overarching table that summarises the level of functioning across different ADLs or an 'ADL profile' will be developed, and if there are sufficient data, these will be separated based on the phases of BD, such as manic/hypomanic, depressed and euthymic.
As this systematic review uses information from previous literature, this review does not require ethics approval. This review will help identify the trends in daily activities that individuals struggle with and can help healthcare practitioners identify specific areas of need for support. We plan to disseminate the results in a peer-reviewed journal and conferences targeting occupational therapists and mental health clinicians.
CRD42021255089.
双相情感障碍（BD）是一种严重的精神健康障碍，影响着 2%的成年人口。患有这种疾病的人患病和功能困难的风险更高。他们在日常生活活动（ADL）中也可能面临重大挑战。本系统评价将确定所有研究，这些研究都检查了影响 BD 患者的 ADL 亚组。
将对 MEDLINE、Embase、CINAHL 和 APA PsycINFO 进行检索，以确定研究功能、独立性或各种 ADL 表现的观察性研究。将进行标题和摘要、全文筛选以及偏倚风险评估的重复检查。将制定一个总结不同 ADL 或“ADL 特征”的功能水平的总表，如果有足够的数据，将根据 BD 的不同阶段（如躁狂/轻躁狂、抑郁和稳定）进行分离。
由于本系统评价使用了以前文献中的信息，因此本评价不需要伦理批准。本综述将有助于确定个体在日常活动中面临困难的趋势，并帮助医疗保健从业者确定需要支持的具体领域。我们计划在同行评议期刊和针对职业治疗师和心理健康临床医生的会议上发表结果。
PROSPERO 注册号：CRD42021255089。
